QA: Orgenesis Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001460602_2022_Orgenesis_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001460602, Orgenesis Inc

  xvar xval
0 AssetsCurrent 25,758,000
1 IntangibleAssetsNetIncludingGoodwill 20,224,000
2 PropertyPlantAndEquipmentNet 10,271,000
3 remainder_Assets 3,588,000
4 LiabilitiesCurrent 15,365,000
5 LiabilitiesNoncurrent 5,845,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,456,303
9 ResearchAndDevelopmentExpense 54,779,258
10 remainder_Expenses 1,092,159
11 remainder_Revenues 14,716,538
12 remainder_NetIncome -92,883,960
13 remainder_ComprehensiveNetIncome -742,358
  yvar yval
0 Assets 59,841,000
1 Liabilities 21,210,000
2 Expenses 68,327,720
3 Revenues 14,716,538
4 StockholdersEquity 38,631,000
5 NetIncome -146,495,142
6 ComprehensiveNetIncome -146,866,321
7 BaseVar 128,860,788
8 EconomicCapitalRatiobeforeLimitedLiability -1.55
9 EconomicCapitalRatio 1.17

Edgar->Model Mapping

Feature Distribution

Change over Time